Intervention With Anti-Inflammatory Resolvin E1 Attenuates Atherosclerosis Without Decreasing Plasma Cholesterol and Adds to the Antiatherogenic Effect of Atorvastatin

被引：0
|
作者：
Salic, Kanita
Wielinga, Peter W.
Van der Hoorn, Jose W.
Verschuren, Lars
Kleemann, Robert
Gjorstrup, Per
Kooistra, Teake
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A637
引用
收藏
页数：2
相关论文
共 16 条
  • [1] INTERVENTION WITH ANTI-INFLAMMATORY RVE1 ATTENUATES ATHEROSCLEROSIS WITHOUT DECREASING PLASMA CHOLESTEROL AND ADDS TO THE ANTI-ATHEROGENIC EFFECT OF ATORVASTATIN
    Salic, K.
    Wielinga, P. Y.
    Verschuren, L.
    Gjorstrup, P.
    Kleemann, R.
    Kooistra, T.
    ATHEROSCLEROSIS, 2014, 235 (02) : E267 - E267
  • [2] Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin
    Salic, Kanita
    Morrison, Martine C.
    Verschuren, Lars
    Wielinga, Peter Y.
    Wu, Lijun
    Kleemann, Robert
    Gjorstrup, Per
    Kooistra, Teake
    ATHEROSCLEROSIS, 2016, 250 : 158 - 165
  • [3] Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions
    Arita, Makoto
    Oh, Sungwhan F.
    Chonan, Tomomichi
    Hong, Song
    Elangovan, Siva
    Sun, Yee-Ping
    Uddin, Jasim
    Petasis, Nicos A.
    Serhan, Charles N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (32) : 22847 - 22854
  • [4] Synthesis of Resolvin E1 and Its Conformationally Restricted Cyclopropane Congeners with Potent Anti-Inflammatory Effect
    Ishimura, Kohei
    Fukuda, Hayato
    Fujiwara, Koichi
    Muromoto, Ryuta
    Hirashima, Koki
    Murakami, Yuto
    Watanabe, Mizuki
    Ishihara, Jun
    Matsuda, Tadashi
    Shuto, Satoshi
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (02): : 256 - 261
  • [5] Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1
    Seki, Hiroyuki
    Tani, Yukako
    Arita, Makoto
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2009, 89 (3-4) : 126 - 130
  • [6] Stereoselective synthesis of the specialized pro-resolving and anti-inflammatory mediator resolvin E1
    Nesman, Jannicke Irina
    Tungen, Jorn Eivind
    Vik, Anders
    Hansen, Trond Vidar
    TETRAHEDRON, 2020, 76 (03)
  • [7] The anti-inflammatory and antiatherogenic effect of nad-containing drug on early atherosclerosis in high cholesterol fed rabbits
    Gongadze, N. V.
    Kezeli, T. D.
    Mitagvari, N. P.
    Sukoyan, G. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 242 - 242
  • [8] Altered anti-inflammatory resolvin E1 in an in vivo model of age-related macular degeneration
    Tisi, A.
    Carozza, G.
    Maccarone, R.
    Maccarrone, M.
    FEBS OPEN BIO, 2022, 12 : 270 - 270
  • [9] The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
    Zhang, Jishou
    Wang, Menglong
    Ye, Jing
    Liu, Jianfang
    Xu, Yao
    Wang, Zhen
    Ye, Di
    Zhao, Mengmeng
    Wan, Jun
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] The Anti-Inflammatory and Proresolving Mediator Resolvin E1 Protects Mice from Bacterial Pneumonia and Acute Lung Injury
    Seki, Hiroyuki
    Fukunaga, Koichi
    Arita, Makoto
    Arai, Hiroyuki
    Nakanishi, Hiroki
    Taguchi, Ryo
    Miyasho, Taku
    Takamiya, Rina
    Asano, Koichiro
    Ishizaka, Akitoshi
    Takeda, Junzo
    Levy, Bruce D.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (02): : 836 - 843
12